GTDataGroup LegalCore

Texas legal research

GV chapter 438

Sec. 438.204. DRUG SUPPLY CHAIN AUDIT; REPORT.

Government Code § 438.204

(a) In this section, "company subject to the jurisdiction of a foreign adversary" includes a state-owned enterprise of a foreign adversary, a company domiciled or headquartered in the territory of a foreign adversary, or any wholly owned or majority-owned subsidiary of a company domiciled or headquartered in the territory of a foreign adversary.

(b) The advisory committee, in collaboration with the Health and Human Services Commission and the Department of State Health Services, shall investigate the drug supply chain of this state to identify prescription drugs, including active pharmaceutical ingredients and key starting materials, that are produced in or by a foreign adversary or substantially sourced from a company subject to the jurisdiction of a foreign adversary.

(c) The advisory committee shall investigate whether the prescription drugs identified under Subsection (b):

(1) are of low or questionable efficacy; or

(2) are toxic or contain impurities known to the United States Food and Drug Administration, the United States Department of Agriculture, or any other governmental agencies to pose a risk to human health.

(d) The advisory committee shall study whether the drug supply chain of the prescription drugs identified under Subsection (b) would be disrupted in the event of a geopolitical conflict.

(e) The advisory committee shall produce an initial report on the prescription drugs identified under Subsection (b). The initial report must:

(1) list the prescription drugs;

(2) identify the classes and common uses of the prescription drugs;

(3) assess the risk posed by the prescription drugs, including concerns related to quality, efficacy, toxicity, or impurity;

(4) determine the impact of a geopolitical conflict on the drug supply chain of the prescription drugs;

(5) recommend alternative sourcing strategies for the prescription drugs in the event of a geopolitical conflict;

(6) describe any difficulty in identifying or using alternative sourcing strategies under Subdivision (5) for prescription drugs, as necessary; and

(7) determine the feasibility and cost of creating and maintaining a strategic supply of prescription drugs in the event of a geopolitical conflict.

(f) The advisory committee shall submit the initial report of prescription drugs identified under this section to the governor not later than October 1, 2026.

(g) The advisory committee may conduct additional investigations and produce additional reports on the prescription drugs identified under Subsection (b) as the committee determines necessary.

Added by Acts 2025, 89th Leg., R.S., Ch. 94 (S.B. 2312), Sec. 1, eff. September 1, 2025.

Source details
canonical id
tx-statute:gv:438.204
provision id
tx-statute:gv:[email protected]
version id
tx-statute:gv:[email protected]~6ac43447a15553e7
record id
tx-statute:gv:[email protected]
document id
tx-statute-chapter:gv:438
record sha256
5d501bea8b79490c636790f54f9f73776654ae4c63f4cbf182ef4db8df07445d
anchor id
p-438-204-193124-197931
legalcore record url
https://legalcore.example.invalid/tx/statutes/gv/sections/438.204/193124.197931

Source locations are recorded for verification and are not links.

References in this section

  • Sec. 438.204. DRUG SUPPLY CHAIN AUDIT; REPORT.
    Reference details
    original href
    https://statutes.capitol.texas.gov/Docs/GV/htm/GV.438.htm#438.204
    target fragment
    438.204
    source context
    paragraph
    resolution reason
    unique prepared provision #438.204 in tx-statute-chapter:gv:438
    expected target id
    tx-statute:gv:438.204
    source document id
    tx-statute-chapter:gv:438
    source provision id
    tx-statute:gv:[email protected]
    target document id
    tx-statute-chapter:gv:438
    target provision id
    tx-statute:gv:[email protected]
    target version id
    tx-statute:gv:[email protected]~6ac43447a15553e7
    candidate
    tx-statute:gv:[email protected]
    resolution status
    resolved

    Source locations are recorded for verification and are not links.

  • 2312 Target unavailable; not linked
    Reference details
    original href
    http://capitol.texas.gov/tlodocs/89R/billtext/html/SB02312F.HTM
    source context
    paragraph
    resolution reason
    target family not prepared (legislative_bill_text)
    source document id
    tx-statute-chapter:gv:438
    source provision id
    tx-statute:gv:[email protected]
    resolution status
    unavailable

    Source locations are recorded for verification and are not links.

Cited by

  • GV § 438.204 cites it as “Sec. 438.204. DRUG SUPPLY CHAIN AUDIT; REPORT.”
    Reference details
    original href
    https://statutes.capitol.texas.gov/Docs/GV/htm/GV.438.htm#438.204
    target fragment
    438.204
    source context
    paragraph
    resolution reason
    unique prepared provision #438.204 in tx-statute-chapter:gv:438
    expected target id
    tx-statute:gv:438.204
    source document id
    tx-statute-chapter:gv:438
    source provision id
    tx-statute:gv:[email protected]
    target document id
    tx-statute-chapter:gv:438
    target provision id
    tx-statute:gv:[email protected]
    target version id
    tx-statute:gv:[email protected]~6ac43447a15553e7
    candidate
    tx-statute:gv:[email protected]
    resolution status
    resolved

    Source locations are recorded for verification and are not links.

Citations show recorded connections only, not legal effect or validity.